The Karches Center for Oncology Research, Institute for Molecular Medicine, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 350 Community Drive, Manhasset, NY 11030, USA.
The Karches Center for Oncology Research, Institute for Molecular Medicine, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 350 Community Drive, Manhasset, NY 11030, USA.
Hematol Oncol Clin North Am. 2021 Aug;35(4):665-685. doi: 10.1016/j.hoc.2021.03.002. Epub 2021 Jun 2.
Chronic lymphocytic leukemia (CLL) is a common, incurable disease of undefined cause. Notably, the normal cell equivalents of CLL cells remain elusive, and it is possible that the disease emanates from several normal B-cell subsets. This article reviews the literature relating to this issue, focusing on recent findings, in particular made through epigenetic analyses that strongly support the disease developing from a normal Ag-experienced and memory cell-like B lymphocyte. It also reports the known pathways whereby normal B lymphocytes mature after antigenic challenge and proposes that this information is relevant in defining the cells of origin of this disease.
慢性淋巴细胞白血病(CLL)是一种常见的、无法治愈的疾病,其病因尚未明确。值得注意的是,CLL 细胞的正常细胞对应物仍难以捉摸,而且这种疾病可能起源于几种正常 B 细胞亚群。本文综述了与这一问题相关的文献,重点关注最近的发现,特别是通过表观遗传学分析得出的有力支持该疾病由正常 Ag 经历和记忆细胞样 B 淋巴细胞发展而来的发现。本文还报告了已知的正常 B 淋巴细胞在抗原刺激后成熟的途径,并提出这些信息与确定该疾病的起源细胞相关。